PARTICULAR ASPECTS IN PATIENTS WITH PARANEOPLASTIC DEEP VEIN THROMBOSIS: FROM A SHADOWY DIAGNOSIS TO A ROUTINELY MET PATHOLOGY
The oncological patient presents many pathophysiological particularities, including a hypercoagulable state, which causes frequent thromboembolic complications. Furthermore, the side effects of chemotherapy, laborious surgical interventions and the poor performance status favor the occurrence of deep vein thrombosis (DVT). The aim of this retrospective study is to identify the prevalence of paraneoplastic DVT in patients admitted in the Cardiology Department of the “Sf. Spiridon” County Clinical Emergency Hospital from Iași and to establish the correlations between the DVT, type of neoplasia and certain particularities of the patients. Material and methods: The current retrospective study was conducted over a two-year period and enrolled 100 patients divided into two groups based on the presence or absence of a neoplasia (25 patients having a tumoral pathology and 75 patients without such a comorbidity). All study participants underwent a complete clinical examination and were assessed through biochemical and echocardiographic parameters. Results: Various tumor locations were identified in the 25 patients with a malignancy, the most prevalent being the colorectal cancer (6 cases, 24% of total), followed by the lung cancer (4 cases, 16%) and, with a similar occurrence, the brain, ovarian and breast cancer (2 cases each, 8%). Among the patients with neoplasia, 13 had a history of cancer (52% of cases from the neoplasia group), while for the remaining 12 patients it was a de novo diagnosis. Conclusions: Patients with DVT showed a significant cancer prevalence, either previously diagnosed or incidentally discovered. The increased risk of DVT in cancer patients is multifactorial and represents a diagnosis and therapeutic challenge. In our study, we recorded a slightly increased prevalence of cancer in women (56% vs. 44%), who had cervical cancer as the most common etiology (35.7%). On the other hand, male sex was associated with an increased frequency of colorectal cancer (36.4% of all cancers diagnosed in men), followed by lung cancer (27.3%).
2. Konstantinides SV, Barco S, Lankeit M, Meyer G. Management of Pulmonary Embolism: An Update. Journal of the American College of Cardiology 2016; 67(8): 976-990.
3. Deitelzweig SB, Johnson BH, Lin J, Schulman KL. Prevalence of clinical venous thromboembolism in the USA: current trends and future projections. American Journal of Hematology 2011; 86 (2): 217-220.
4. Mazzolai L, Aboyans V, Ageno W, Agnelli G, et al. Diagnosis and management of acute deep vein thrombosis: A joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function. Euro-pean Heart Journal 2018; 39(15): 1316.
5. Costache II, Scripcariu V. Evaluarea cardiovasculară preoperatorie în chirurgia oncologică. Editura “Gr. T. Popa” Iași, 2019.
6. Razak NBA, Jones G, Bhandari M, Berndt MC, Metharom P. Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment. Cancers 2018; 10(10): 380.
7. Renni MJP, Cerqueira M H, de Araújo Trugilho I, Cordeiro Araujo ML, Marques MA, Koch HA. Mechanisms of venous thromboembolism in cancer: A literature review. Journal Vascular Brasileiro, 2017; 16(164): 308-313.
8. Cohen A, Lim CS, Davies AH. Venous Thromboembolism in Gynecological Malignancy. Int J Gyne-col Cancer 2017; 27(9): 1970-1978.
9. Rees PA, Clouston HW, Duff S, Kirwan CC. Colorectal cancer, and thrombosis. International journal of colorectal disease 2018; 33(1): 105-108.
10. Cerrito L, Annicchiarico BE, Iezzi R, Gasbarrini A, Pompili M, Ponziani FR. Treatment of hepatocel-lular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers. World Journal of Gastroenterology 2019; 25(31): 4360-4382.
11. Miftode RS, Mitu O, Arhirii RE, Costache II, Petris A. Giant thrombus occupying the right cardiac chambers in a cancer patient: An unusual and incidental discovery. Anatol J Cardiol 2020; 24(2): E5.
12. Schaffner F, Ruf W. Tissue factor and protease-activated receptor signaling in cancer. Semin Thromb Hemost 2008; 34(2): 147-153.
13. Grandoni F, Alberio L. Direct Oral Anticoagulant Drugs: On the Treatment of Cancer-Related Venous Thromboembolism and their Potential Anti-Neoplastic Effect. Cancers (Basel) 2019; 11(1): 46.
14. Chew HK, Wun T, Harvey D, Zhou H, White RH. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 2006; 166: 458-464.
15. Jara-Palomares L, Otero R, Jiménez D, et al. Sex Differences in Patients with Occult Cancer After Venous Thromboembolism. Clinical and Applied Thrombosis / Hemostasis 2018; 24(3): 489-495.
16. Rouzaud D, Alexandra JF, Chauchard M, et al. Frequency of malignancy is high in patients admitted for a first venous thromboembolism episode: an observational study. Journal of Thrombosis and Thrombolysis 2016; 42(3): 329-335.
17. Ihaddadene R, Corsi DJ, Lazo-Langner A, Shivakumar S, Zarychansky R, Tagalakis V, et al. Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism. Blood 2016; 127(16): 2035-2037.
18. Fahrig C, Heidrich H, Penninger C. The incidence of occult malignant diseases in patients with deep venous thrombosis of the pelvis and lower limb. International Journal of Angiology 1998; 7(3): 249-251.
19. Hettiarachchi RJK, Lok J, Prins MH, Büller HR, Prandoni P. Undiagnosed malignancy in patients with deep vein thrombosis: Incidence, risk indicators, and diagnosis. Cancer, 1998; 83(1): 180-185.
20. Prandoni P, Lensing AW, Büller HR, Cogo A, Prins MH, Cattelan AM, et al. Deep-Vein Thrombosis and the Incidence of Subsequent Symptomatic Cancer. New England Journal of Medicine 1992; 327(16): 1128-1133.
21. Li Y, Shang Y, Wang W, Ning S, Chen H. Lung Cancer and Pulmonary Embolism: What Is the Rela-tionship? A Review. J Cancer 2018; 9(17): 3046-3057.
22. Wang J, Zhou W, Xu L, Yang M, Meng L, Fan W, et al. Risk factors and prognosis of lung cancer combined with pulmonary embolism. Chinese Journal of Lung Cancer 2011; 14: 780-784.
23. Davies NA, Harrison NK, Sabra A, Lawrence MJ, Noble S, Davidson SJ, et al. Application of ROTEM to assess hypercoagulability in patients with lung cancer. Thrombosis research 2015; 135: 1075-1080.
24. Chi G, Gibson CM, Hernandez AF, Hull RD, Kazmi SHA, et al. Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy. Am J Med 2018; 131(8): 972.e1-972.e7.
25. Carrier M, Lazo-Langner A, Shivakumar S, Tagalakis V, Zarychansky R, Solymoss S, et al. Screening for occult cancer in unprovoked venous thromboembolism. New England Journal of Medicine 2015; 378(8): 697-704.
Once an article is accepted for publication, MSJ requests a transfer of copyrights for published articles.
COPYRIGHT TRANSFER FORM FOR
REVISTA MEDICO-CHIRURGICALĂ A SOCIETĂȚII DE MEDICI ȘI NATURALIȘTI DIN IAȘI /
THE MEDICAL-SURGICAL JOURNAL OF THE SOCIETY OF PHYSICIANS AND NATURALISTS FROM IASI
We, the undersigned authors of the manuscript entitled
warrant that this manuscript, which is submitted for publication in the REVISTA MEDICO-CHIRURGICALĂ, has not been published and it is not under consideration for publication in another journal.
- we give the consent for publication in the REVISTA MEDICO-CHIRURGICALĂ, in printed and electronic format and we transfer unconditioned and complete the copyright of this manuscript to the REVISTA MEDICO-CHIRURGICALĂ, in the event of its acceptance.
- the manuscript does not break the intellectual property rights of any other person.
- we have read the submitted version of the manuscript and we are fully responsible for the content.
Names and signatures of authors / copyright owners (the following sequence is the authorship of the article):
N.B. All the authors must sign this form